NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 51 filers reported holding NOVELION THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $103,000 | -19.5% | 34,828 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $128,000 | +4.9% | 34,828 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $122,000 | +11.9% | 34,828 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $109,000 | -55.5% | 34,828 | 0.0% | 0.00% | -60.0% |
| Q3 2017 | $245,000 | -23.7% | 34,828 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $321,000 | -14.2% | 34,828 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $374,000 | +15.1% | 34,828 | -9.7% | 0.01% | +20.0% |
| Q4 2016 | $325,000 | – | 38,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|